AmpliPhi Biosciences Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 13

  • Investments
  • 5

AmpliPhi Biosciences General Information

Description

Developer of bacteriophage technology intended to control human diseases. The company is focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious diseases of the microbiome, enabling healthcare professionals to get novel therapies to cure their patients efficiently.

Contact Information

Website
www.targen.com
Formerly Known As
Targeted Genetics, Genevo
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3579 Valley Centre Drive
  • Suite 100
  • San Diego, CA 92130
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3579 Valley Centre Drive
  • Suite 100
  • San Diego, CA 92130
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmpliPhi Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AmpliPhi Biosciences‘s full profile, request access.

Request a free trial

AmpliPhi Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bacteriophage technology intended to control human diseases. The company is focused on improving human heal
Drug Discovery
San Diego, CA

Plymouth Meeting, PA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmpliPhi Biosciences Competitors (7)

One of AmpliPhi Biosciences’s 7 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Spero Therapeutics Formerly VC-backed Cambridge, MA
VBI Vaccines Corporation Cambridge, MA
Achaogen Formerly VC-backed South San Francisco, CA
Aridis Pharmaceuticals Formerly VC-backed Los Gatos, CA
You’re viewing 5 of 7 competitors. Get the full list »

AmpliPhi Biosciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AmpliPhi Biosciences‘s full profile, request access.

Request a free trial

AmpliPhi Biosciences Acquisitions (5)

AmpliPhi Biosciences’s most recent deal was a Reverse Merger with Armata Pharmaceuticals. The deal was made on 10-May-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Armata Pharmaceuticals 10-May-2019 Reverse Merger Drug Discovery
Novolytics 08-Jan-2016 Merger/Acquisition Biotechnology
Special Phage Services 13-Nov-2012 Merger/Acquisition Pharmaceuticals
Biocontrol 07-Jan-2011 Merger/Acquisition Drug Discovery
RGene Therapeutics 16-Apr-1996 Merger/Acquisition Drug Discovery
To view AmpliPhi Biosciences’s complete acquisitions history, request access »

AmpliPhi Biosciences Exits (1)

AmpliPhi Biosciences’s most recent exit was on 10-May-2019 from Armata Pharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Armata Pharmaceuticals 10-May-2019 Completed
To view AmpliPhi Biosciences’s complete exits history, request access »

AmpliPhi Biosciences FAQs

  • When was AmpliPhi Biosciences founded?

    AmpliPhi Biosciences was founded in 1989.

  • Where is AmpliPhi Biosciences headquartered?

    AmpliPhi Biosciences is headquartered in San Diego, CA.

  • What industry is AmpliPhi Biosciences in?

    AmpliPhi Biosciences’s primary industry is Drug Discovery.

  • Is AmpliPhi Biosciences a private or public company?

    AmpliPhi Biosciences is a Private company.

  • What is AmpliPhi Biosciences’s current revenue?

    The current revenue for AmpliPhi Biosciences is .

  • How much funding has AmpliPhi Biosciences raised over time?

    AmpliPhi Biosciences has raised $53.3M.

  • Who are AmpliPhi Biosciences’s investors?

    Activation Capital, Burnbrae Group, E-Synergy, Enterprise Partners Venture Capital, and GeneChem are 5 of 12 investors who have invested in AmpliPhi Biosciences.

  • Who are AmpliPhi Biosciences’s competitors?

    Inovio Pharmaceuticals, Spero Therapeutics, VBI Vaccines, Achaogen, and Aridis Pharmaceuticals are some of the 7 competitors of AmpliPhi Biosciences.

  • When was AmpliPhi Biosciences acquired?

    AmpliPhi Biosciences was acquired on 10-May-2019.

  • Who acquired AmpliPhi Biosciences?

    AmpliPhi Biosciences was acquired by Armata Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process